PROTEON THERAPEUTICS INC
Profile
Company Names
PROTEON THERAPEUTICS INC
Addresses
200 WEST STREET, WALTHAM, MA 02451
Phone Numbers
781-890-0102
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$71,087,965.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2017-08-02
$22,000,000.00
$22,000,000.00
$0.00
Equity
3
2014-05-13
$29,565,934.00
$29,565,934.00
$0.00
Equity
2
2013-09-04
$4,338,660.00
$4,338,660.00
$0.00
Equity, Debt
1
2011-08-02
$15,183,371.00
$15,183,371.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
HUBERT
BIRNER
DIRECTOR
GAREN
BOHLIN
DIRECTOR
TODD
FOLEY
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.
| ZALICUS INC.
| CELLADON CORP
| SELEXYS PHARMACEUTICALS CORP
| PROTEON THERAPEUTICS INC
| ICONIC THERAPEUTICS INC
| VALERITAS INC
| TETHEREX PHARMACEUTICALS CORP
| CLINICAL INK, INC.
| SEMMA THERAPEUTICS, INC.
| RHYTHM METABOLIC, INC.
| RHYTHM PHARMACEUTICALS, INC.
| ENTRADA THERAPEUTICS, INC.
| MOAT BIOTECHNOLOGY CORP
| CROSSBOW THERAPEUTICS, INC.
| FIREFLY BIO, INC.
| AKTIS ONCOLOGY, INC.
JOHN
G.
FREUND
DIRECTOR
STEPHEN
HOFFMAN
DIRECTOR
JONATHAN
LEFF
DIRECTOR
HANA BIOSCIENCES INC
| RIB X PHARMACEUTICALS INC
| TALON THERAPEUTICS, INC.
| N30 PHARMACEUTICALS, INC.
| AUDENTES THERAPEUTICS, INC.
| AVEXIS, INC.
| APRECIA PHARMACEUTICALS CO
| PROTEON THERAPEUTICS INC
| DRACEN PHARMACEUTICALS, INC.
| ARS PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC
| LARIMAR THERAPEUTICS, INC.
| AVALYN PHARMA INC.
| AEROVATE THERAPEUTICS, INC.
| ADAPTIVE PHAGE THERAPEUTICS, INC.
| INNERVACE, INC.
| BIOMX INC.
| ELION THERAPEUTICS, INC.
| AXONIS THERAPEUTICS, INC.
DAVID
G.
LOWE
DIRECTOR
BRENDAN
O-LEARY
DIRECTOR
STEVEN
ST. PETER
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2017-08-02
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

